home / stock / ppcb / ppcb quote
Last: | $0.001 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0008 |
Close: | $0.001 |
High: | $0.001 |
Low: | $0.00075 |
Volume: | 35,421,162 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.001 | $0.0008 | $0.001 | $0.001 | $0.00075 | 35,421,162 | 07-17-2024 |
$0.0008 | $0.0007 | $0.0008 | $0.0008 | $0.0007 | 5,024,867 | 07-16-2024 |
$0.00075 | $0.0008 | $0.00075 | $0.0008 | $0.0007 | 5,581,552 | 07-15-2024 |
$0.00075 | $0.0008 | $0.00075 | $0.0008 | $0.0007 | 33,836,032 | 07-12-2024 |
$0.00084 | $0.0008 | $0.00084 | $0.0009 | $0.00075 | 10,078,135 | 07-11-2024 |
$0.0008 | $0.0008 | $0.0008 | $0.0009 | $0.0008 | 11,045,428 | 07-10-2024 |
$0.00084 | $0.00095 | $0.00084 | $0.001 | $0.0008 | 44,313,368 | 07-09-2024 |
$0.001 | $0.001 | $0.001 | $0.001 | $0.0009 | 11,856,875 | 07-08-2024 |
$0.00095 | $0.0011 | $0.00095 | $0.0011 | $0.0009 | 9,977,871 | 07-05-2024 |
$0.0011 | $0.0011 | $0.00105 | $0.0012 | $0.001 | 11,727,243 | 07-04-2024 |
$0.00105 | $0.0011 | $0.00105 | $0.00115 | $0.001 | 11,727,243 | 07-03-2024 |
$0.0012 | $0.0012 | $0.0012 | $0.0013 | $0.00105 | 23,615,230 | 07-02-2024 |
$0.0013 | $0.0013 | $0.0013 | $0.0013 | $0.0012 | 5,781,102 | 07-01-2024 |
$0.00125 | $0.0015 | $0.00125 | $0.0015 | $0.0012 | 16,370,074 | 06-28-2024 |
$0.0014 | $0.0014 | $0.0014 | $0.0015 | $0.0012 | 11,591,656 | 06-27-2024 |
$0.0013 | $0.0014 | $0.0013 | $0.0014 | $0.0012 | 14,484,673 | 06-26-2024 |
$0.00135 | $0.0013 | $0.00135 | $0.0017 | $0.0012 | 70,071,284 | 06-25-2024 |
$0.0011 | $0.0013 | $0.0011 | $0.0013 | $0.0011 | 24,293,452 | 06-24-2024 |
$0.00115 | $0.0016 | $0.00115 | $0.0017 | $0.00115 | 70,618,159 | 06-21-2024 |
$0.0015 | $0.0013 | $0.0015 | $0.0018 | $0.0012 | 49,052,546 | 06-20-2024 |
News, Short Squeeze, Breakout and More Instantly...
Propanc Biopharma Inc Company Name:
PPCB Stock Symbol:
OTCMKTS Market:
Propanc Biopharma Inc Website:
British Journal of Cancer Concludes Tumor cell-intrinsic PD-L1 function promotes EMT Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recu...
Certificate of Grant Received for “Cancer Treatment” Patent from IP Corporation of Malaysia Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patient...
Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that a certificate of grant for the Company’s &...